Treating early rheumatoid arthritis in the younger patient

Journal of Rheumatology

Volumn 28, Issue SUPPL. 62, 2001, Pages 4-9

  Bresnihan, B ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Drug treatment for rheumatoid arthritis; Early diagnosis of rheumatoid arthritis; Fertility and family planning; Rheumatoid arthritis

Indexed keywords

ACUTE PHASE PROTEIN; CORTICOSTEROID; HYDROXYCHLOROQUINE; METHOTREXATE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

CONFERENCE PAPER; EARLY DIAGNOSIS; FAMILY PLANNING; FERTILITY; HUMAN; LACTATION; PREGNANCY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT INDICATION; ADULT; FEMALE; MIDDLE AGED; PREGNANCY COMPLICATION; REVIEW;

ADULT; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0034985276     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. The optimal management of early rheumatoid arthritis: The key to preventing disability
2. When does rheumatoid arthritis begin and why do we need to know?
3. The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome
4. Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression
5. Serum amyloid A in the assessment of early inflammatory arthritis
6. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide
7. Immunohistological features of synovitis in ankylosing spondylitis: A comparison with rheumatoid arthritis
8. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis
9. Immunohistologic analysis of peripheral joint disease in ankylosing spondylitis
10. Analysis of the cellular infiltrates and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis
11. Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis
12. Radiographic progression of rheumatoid arthritis related to some clinical and laboratory parameters
13. Radiographic assessment in relation to clinical and biochemical variables in rheumatoid arthritis
14. Interrelationships of outcome measures and process variables in early rheumatoid arthritis: A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants
15. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis
16. Immunohistologic analysis of the synovial membrane seeking predictors of the clinical course in rheumatoid arthritis
17. Synovial tissue macrophages and joint erosion in rheumatoid arthritis
18. Pathogenesis of joint damage in rheumatoid arthritis
19. Protease gene expression in synovial tissue and joint damage in early inflammatory arthritis
20. Continuous progression of radiological destruction in rheumatoid arthritis
21. Radiographic outcome of recent-onset rheumatoid arthritis. A 19 year study of radiographic progression
22. Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification)
23. Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis
24. Polyglot and polymorphism. An HLA update
25. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome
26. The influence of HLA-DRB1 alleles and rheumatoid factor on disease outcome in an inception cohort of patients with early inflammatory arthritis
27. Association of HLA alleles and clinical features in patients with synovitis of recent onset
28. HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis
29. The effect of glucocorticoid on joint destruction in rheumatoid arthritis
30. Treatment of early rheumatoid arthritis with minocycline or placebo. Results of a randomized, double-blind, placebo-controlled trial
31. Efficacy and safety of leflunomide compared with placebo and sulfasalazine in active rheumatoid arthritis: A double-blind, randomised, multicentre trial
32. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
33. Randomized comparison of combined step-down prednisolone, methotrexate and sulfasalazine with sulfasalazine alone in early rheumatoid arthritis
34. Combination of sulfasalazine and methotrexate versus the single components in early rheumatoid arthritis: A randomized, controlled, double-blind, 52 week clinical trial
35. Combination therapy in early rheumatoid arthritis: A randomized, controlled, double blind 52 week clinical trial of sulfasalazine and methotrexate compared with the single components
36. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation
37. Placental transfer of sulphasalazine and sulphapyridine and some of its metabolites
38. Bloody diarrhea: A possible complication of sulfasalazine transferred through human breast milk